Oramed Pharmaceuticals Inc.
ORMP· Nasdaq
ORMPOramed Pharmaceuticals Inc.
Filed Nov 14, 2014 · 10-K · 75 days after period end · 0001178913-14-003555
derived · Computed from the longer spans the company filed.
| Metric | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$5.29M | $7.67M | -$1.33M | -$773.04K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oramed Pharmaceuticals Inc. · CIK 1176309 · Engraved from SEC EDGAR
ended Aug 31, 2014 · filed Nov 14, 2014 · 75 d after period end
